BioCorRx Inc. (OTC:BICX)

Health Care/Life Sciences • Healthcare Provision

CIK 1443863

Company

BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA.

Address
2390 East Orangewood Avenue
Suite 500
Anaheim, California 92806

Employees
3

Stock Info

Close
$1.0000

Day Range
0.9950 - 0.9950

52 Week Range
0.6720 - 2.2200

Average volume
1.39K

Short Interest
N/A (N/A)

% of Float Shorted
N/A

Market Cap
$7.91M

Revenue
$213.84K

Net Income
-$4.37M

2020 Sales Growth
N/A

Rev. per Employee
$51.03K

P/E Ratio
N/A

EPS
-$0.4920

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Kent Emry

Director, CFO, Chief Executive & Operating Officer
Lourdes Felix MBA

Director
Joseph John Galligan CFA

Director
Katherine L Beebe-DeVarney PhD

Director
Harsha Murthy

Director
Brady James Granier

Independent Director
Luisa I Ingargiola MBA

SEC filings

Date	Form	Event
14 Nov, 2024	10-Q
13 Aug, 2024	10-Q
10 Jul, 2024	4
10 Jul, 2024	8-K
8 Jul, 2024	4
8 Jul, 2024	4
3 Jun, 2024	4
15 May, 2024	10-Q
1 May, 2024	4
5 Apr, 2024	4
3 Apr, 2024	4
3 Apr, 2024	4
3 Apr, 2024	8-K
3 Apr, 2024	4
3 Apr, 2024	4
1 Apr, 2024	10-K
7 Mar, 2024	4
17 Jan, 2024	4
5 Jan, 2024	8-K	CEO Change
4 Jan, 2024	4
4 Jan, 2024	4
4 Jan, 2024	4
4 Jan, 2024	4
15 Dec, 2023	8-K
16 Nov, 2023	8-K
14 Nov, 2023	10-Q
2 Nov, 2023	8-K	CEO Change
3 Oct, 2023	4
3 Oct, 2023	4
2 Oct, 2023	4
2 Oct, 2023	4
2 Oct, 2023	4
2 Oct, 2023	4
2 Oct, 2023	4
14 Aug, 2023	10-Q
6 Jul, 2023	4
5 Jul, 2023	4
5 Jul, 2023	4
5 Jul, 2023	4
5 Jul, 2023	4
5 Jul, 2023	4
5 Jul, 2023	4
15 May, 2023	10-Q
11 Apr, 2023	8-K
5 Apr, 2023	8-K
5 Apr, 2023	4
3 Apr, 2023	4
3 Apr, 2023	4
3 Apr, 2023	4
3 Apr, 2023	4
3 Apr, 2023	4
31 Mar, 2023	10-K
31 Jan, 2023	4
27 Jan, 2023	4
25 Jan, 2023	4
23 Jan, 2023	8-K
23 Jan, 2023	3
17 Jan, 2023	4
9 Jan, 2023	4
6 Jan, 2023	4
4 Jan, 2023	4
4 Jan, 2023	4
4 Jan, 2023	4
15 Dec, 2022	4
14 Nov, 2022	10-Q
27 Oct, 2022	8-K
11 Oct, 2022	4
5 Oct, 2022	4
5 Oct, 2022	4
5 Oct, 2022	4
5 Oct, 2022	4
31 Aug, 2022	4
29 Aug, 2022	4
15 Aug, 2022	10-Q
20 Jul, 2022	4
8 Jul, 2022	4
7 Jul, 2022	4
7 Jul, 2022	4
7 Jul, 2022	4
10 Jun, 2022	8-K
16 May, 2022	10-Q
12 May, 2022	8-K
28 Apr, 2022	8-K
5 Apr, 2022	4
4 Apr, 2022	4
4 Apr, 2022	4
4 Apr, 2022	4
4 Apr, 2022	4
4 Apr, 2022	4
31 Mar, 2022	10-K
2 Mar, 2022	4
2 Mar, 2022	4
15 Feb, 2022	4
19 Jan, 2022	8-K
17 Dec, 2021	4
15 Nov, 2021	10-Q
26 Oct, 2021	4
25 Oct, 2021	4
25 Oct, 2021	4
25 Oct, 2021	4
2 Sep, 2021	8-K
13 Aug, 2021	10-Q
14 Jul, 2021	4
6 Jul, 2021	4
6 Jul, 2021	4
6 Jul, 2021	4
17 May, 2021	10-Q
7 Apr, 2021	4
5 Apr, 2021	4
2 Apr, 2021	4
2 Apr, 2021	4
2 Apr, 2021	4
2 Apr, 2021	4
31 Mar, 2021	10-K
2 Mar, 2021	3
2 Mar, 2021	4
26 Feb, 2021	8-K
22 Feb, 2021	8-K
5 Jan, 2021	4
5 Jan, 2021	4
5 Jan, 2021	4
5 Jan, 2021	4
5 Jan, 2021	4

Last update:2024-03-08 12:06:29.941639

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.